Novel therapeutical tools and methods for treating blindness

Details for Australian Patent Application No. 2009237585 (hide)

Owner Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research

Inventors Balya, David; Roska, Botond; Busskamp, Volker; Lagali, Pamela

Agent Davies Collison Cave

Pub. Number AU-A-2009237585

PCT Pub. Number WO2009/127705

Priority 08155942.9 09.05.08 EP; 08154828.1 18.04.08 EP

Filing date 16 April 2009

Wipo publication date 22 October 2009

International Classifications

C07K 14/215 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

11 November 2010 PCT application entered the National Phase

  PCT publication WO2009/127705 Priority application(s): WO2009/127705

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009237607-Process for converting biomass to coallike material using hydrothermal carbonisation

2009237581-Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives